Surgery Partners, Inc. (SGRY)

NASDAQ: SGRY · Real-Time Price · USD

15.67

+0.49 (3.26%)

Jul 28, 2026, 1:51 PM EDT - Market open

Surgery Partners Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	97.1	98.9	12.5	135.3	87	70.7
Depreciation & Amortization	178.2	176	152.6	118.1	114.8	98.8
Stock-Based Compensation	13	14.8	33.3	17.7	18.4	17.4
Other Adjustments	93.5	95	220.6	86.2	99.3	81.5
Change in Receivables	-55	-53.8	-72.1	-47.2	-35.3	-32.1
Changes in Other Operating Activities	-48.1	-56.6	-46.8	-16.3	-125.4	-149.2
Operating Cash Flow	280	274.3	300.1	293.8	158.8	87.1
Operating Cash Flow Growth	5.50%	-8.60%	2.14%	85.01%	82.32%	-64.72%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-72	-78.7	-90.4	-88.8	-80.6	-57.6
Sale of Property, Plant & Equipment	41.7	46.5	2.6	25.8	12.9	6
Purchases of Investments	-9.5	-13.3	-1.7	-50.3	-95.1	-
Proceeds from Sale of Investments	-	1.5	4.6	1.4	12.8	5.4
Cash Acquisitions	-122.3	-162.1	-378.8	-80	-146.4	-285.8
Other Investing Activities	-23.9	-40.5	-24.8	-33.7	-11.5	0.3
Investing Cash Flow	-183.6	-246.6	-488.5	-225.6	-307.9	-331.7

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Long-Term Debt Issued	1,184	1,203	1,730	826.6	217.8	299.4
Long-Term Debt Repaid	-1,114	-1,040	-1,279	-807.1	-873.3	-343.2
Net Long-Term Debt Issued (Repaid)	70.1	162.8	450.4	19.5	-655.5	-43.8
Issuance of Common Stock	-	-	-	-	857.7	554.2
Net Common Stock Issued (Repurchased)	-	-	-	-	857.7	554.2
Preferred Share Dividends Paid	-	-	-	-	-	-5.1
Other Financing Activities	-209	-220.1	-188.4	-174.7	-160.1	-189
Financing Cash Flow	-143.4	-57.3	262	-155.2	42.1	316.3

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash Flow	-47	-29.6	73.6	-87	-107	71.7

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	208	195.6	209.7	205	78.2	29.5
Free Cash Flow Growth	20.02%	-6.72%	2.29%	162.15%	165.08%	-85.54%
FCF Margin	6.22%	5.91%	6.73%	7.47%	3.08%	1.33%
Free Cash Flow Per Share	1.63	1.54	1.66	1.63	0.85	0.41
Levered Free Cash Flow	52.1	125.6	297.7	20.6	-801.3	-303.9
Unlevered Free Cash Flow	393.47	370.23	45.04	341.73	181.08	155.12

SEC Filings: 10-K · 10-Q